cannabichromene has been researched along with anandamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviello, G; Borrelli, F; Capasso, F; Capasso, R; Di Marzo, V; Gallo, L; Izzo, AA; Orlando, P; Piscitelli, F; Romano, B | 1 |
| Arnold, WR; Das, A; Weigle, AT | 1 |
2 other study(ies) available for cannabichromene and anandamide
| Article | Year |
|---|---|
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
Topics: Amides; Animals; Arachidonic Acids; Cannabinoids; Cannabis; Duodenum; Endocannabinoids; Ethanolamines; Gastrointestinal Agents; Gastrointestinal Motility; Gene Expression Regulation; Ileitis; Ileum; In Vitro Techniques; Jejunum; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Palmitic Acids; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2012 |
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.
Topics: Arachidonic Acids; Cannabinoids; Cells, Cultured; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Dronabinol; Endocannabinoids; Epoxy Compounds; Humans; Polyunsaturated Alkamides | 2018 |